Albumin-corrected fructosamine predicts all-cause and non-CVD mortality among the very elderly aged ≥ 80 years without diabetes.

Jinhui ZhouYuebin LvFeng ZhaoYuan WeiXiang Gao Chen ChenFeng LuYingchun LiuChengcheng LiJiaonan WangXiaochang ZhangHeng GuZhaoxue YinZhaojin CaoVirginia Byers KrausChen MaoXiaoming Shi

Published in: The journals of gerontology. Series A, Biological sciences and medical sciences (2021)

Higher concentrations of fructosamine, AlbF, and FPG were associated with higher risk of all-cause or non-CVD mortality among very elderly where AlbF may constitute an alternative prospective glycemic predictor of mortality.

Keyphrases

cardiovascular events
type diabetes
risk factors
cardiovascular disease
middle aged
glycemic control
community dwelling
metabolic syndrome
skeletal muscle
insulin resistance